MAPT and supranuclear palsy, progressive, 1: Although plasma levels of α-synuclein, DJ-1, and total tau in MSA are reported to be altered compared with controls [10], at present, no clinically established serum/plasma biomarkers for differential diagnosis between MSA and PSP have been identified [3,4].